Germany’s PharmaSGP GmbH posted turnover down by a fifth in the first half of 2021 as the effects of the COVID-19 pandemic continued to impact sales of its consumer health and cosmetics brands.
“Nationwide lockdowns hit our target markets hard, resulting in less footfall in pharmacies, among other effects,” commented CEO Natalie Weigand....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?